L087-1315 Screening compound: N-[(E)-N'-(3,5-dimethoxyphenyl)-N-[(pyridin-3-yl)methyl]carbamimidoyl]-3,4-dimethylbenzamide

L087-1315 Screening compound: N-[(E)-N'-(3,5-dimethoxyphenyl)-N-[(pyridin-3-yl)methyl]carbamimidoyl]-3,4-dimethylbenzamide
L087-1315 Screening compound: N-[(E)-N'-(3,5-dimethoxyphenyl)-N-[(pyridin-3-yl)methyl]carbamimidoyl]-3,4-dimethylbenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L087-1315
N-[(E)-N'-(3,5-dimethoxyphenyl)-N-[(pyridin-3-yl)methyl]carbamimidoyl]-3,4-dimethylbenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L087-1315

Molecular Formula

C24H26N4O3 (C24 H26 N4 O3)

Compound Name

N-[(E)-N'-(3,5-dimethoxyphenyl)-N-[(pyridin-3-yl)methyl]carbamimidoyl]-3,4-dimethylbenzamide

IUPAC name

N-[(E)-N'-(35-dimethoxyphenyl)-N-[(pyridin-3-yl)methyl]carbamimidoyl]-34-dimethylbenzamide

SMILES

Cc(cc1)c(C)cc1C(N/C(/NCc1cnccc1)=N/c1cc(OC)cc(OC)c1)=O

InChI

InChI=1S/C24H26N4O3/c1-16-7-8-19(10-17(16)2)23(29)28-24(26-15-18-6-5-9-25-14-18)27-20-11-21(30-3)13-22(12-20)31-4/h5-14H,15H2,1-4H3,(H2,26,27,28,29)

InChI Key

VKTJOZRSBIBCAV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27230606

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

418.5

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.017

Distribution Coefficient, logD

3.945

Water Solubility, LogSw

-3.89

Polar Surface Area

66.457

Acid Dissociation Constant (pKa)

11.07

Base Dissociation Constant (pKb)

6.66

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.80

L087-1315 in Drug Discovery

Included in Screening Libraries

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L087-1315 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L087-1315?
Check Price and Availability of L087-1315, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L087-1315 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L087-1315
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L087-1315
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L087-1315 available by request